Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q20948663> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q20948663 subject Q10090201.
- Q20948663 subject Q8307291.
- Q20948663 subject Q8798541.
- Q20948663 subject Q9052781.
- Q20948663 abstract "Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, developed by Takeda Pharma. It acts as a proteasome inhibitor and has orphan drug status in the US. In November 2015, the U.S. Food and Drug Administration approved ixazomib for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma after at least one prior therapy.".
- Q20948663 bioavailability "58.0".
- Q20948663 thumbnail Ixazomib.svg?width=300.
- Q20948663 wikiPageWikiLink Q10090201.
- Q20948663 wikiPageWikiLink Q1367466.
- Q20948663 wikiPageWikiLink Q14864419.
- Q20948663 wikiPageWikiLink Q14890102.
- Q20948663 wikiPageWikiLink Q172847.
- Q20948663 wikiPageWikiLink Q18030860.
- Q20948663 wikiPageWikiLink Q204711.
- Q20948663 wikiPageWikiLink Q309110.
- Q20948663 wikiPageWikiLink Q422252.
- Q20948663 wikiPageWikiLink Q425681.
- Q20948663 wikiPageWikiLink Q467635.
- Q20948663 wikiPageWikiLink Q7251235.
- Q20948663 wikiPageWikiLink Q8307291.
- Q20948663 wikiPageWikiLink Q8798541.
- Q20948663 wikiPageWikiLink Q899133.
- Q20948663 wikiPageWikiLink Q9052781.
- Q20948663 bioavailability "58.0".
- Q20948663 type ChemicalSubstance.
- Q20948663 type Drug.
- Q20948663 type ChemicalObject.
- Q20948663 type Thing.
- Q20948663 type Q8386.
- Q20948663 comment "Ixazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, developed by Takeda Pharma. It acts as a proteasome inhibitor and has orphan drug status in the US. In November 2015, the U.S. Food and Drug Administration approved ixazomib for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma after at least one prior therapy.".
- Q20948663 label "Ixazomib".
- Q20948663 depiction Ixazomib.svg.